lung cancer

A novel treatment method developed by researchers targets lung cancer cells with unprecedented precision, using nanoparticles to deliver chemotherapy drugs directly, potentially transforming cancer care by reducing side effects and improving treatment outcomes.Technique employs patient’s own cells as a Trojan horse to deliver cancer-destroying medications directly to tumors.While lung cancer may not be the most common type of cancer, but it is by far the deadliest.Despite treatments such as surgery, radiation therapy, and…

MIT’s inhalable nanosensors could revolutionize lung cancer screening, providing a simple urine test as a viable alternative to CT scans, enhancing global access to early detection. Credit: SciTechDaily.comThe diagnostic, which requires only a simple urine test to read the results, could make lung cancer screening more accessible worldwide.Using a new technology developed at MIT, diagnosing lung cancer could become as easy as inhaling nanoparticle sensors and then taking a urine test that reveals whether a tumor is…

New research in mice may pinpoint how chronic stress can fuel the spread of cancer. The study found evidence that stress can induce changes to certain immune cells that inadvertently make it easier for cancer cells to metastasize and invade other parts of the body. The findings emphasize the need to manage stress following a cancer diagnosis, the scientists say, and could even help efforts to find new treatments.Dave Bautista Opens Up About His Relationship With Denis VilleneuveThe research was led by scientists at Cold…

Researchers catch lung cancer transformation in the act: Immunofluorescence image shows small cell lung cancer (purple-pink) spreading throughout the bronchioles (green) of a mouse lung containing residual lung adenocarcinoma tumor cells (blue). Credit: Dr. Eric Gardner, Varmus LabSometimes, lung tumors known as adenocarcinomas develop resistance to treatments that were initially successful, undergoing a transformation into a more aggressive form of cancer called small cell lung cancer (SCLC), which spreads quickly and…

By Holly Evarts, Columbia University School of Engineering and Applied Science February 16, 2024Illustration showing exosomes (blue) deliver IL-12 mRNA to lung cancer cells (brown). Credit: Cheng Lab/Columbia EngineeringColumbia Biomedical Engineer Ke Cheng has developed a technique that uses inhalation of exosomes, or nanobubbles, to directly deliver IL-12 mRNA to the lungs of mice.Lung cancer is one of the most common cancers and has one of the lowest survival rates in the world. Cytokines, which are small signaling…

By University of Texas M. D. Anderson Cancer Center February 13, 2024A study from The University of Texas MD Anderson Cancer Center reveals that combining targeted therapy and immunotherapy, specifically durvalumab and ceralasertib, significantly benefits patients with non-small cell lung cancer (NSCLC).Phase II trial finds durvalumab plus ceralasertib boosted immune response and improved outcomes in patients with lung cancer.A specific combination of targeted therapy and immunotherapy may better help patients with…

Regular exercise is linked to a lower risk of developing certain cancers, such as those of the head, neck and the lungs, according to a new study. The researchers also found that people who were diagnosed with cancer but exercised still tended to live longer than those who didn’t exercise.Will You Click Windows’ New Copilot Button?Countless studies have found that exercise can blunt the risk of many health problems, cancer included. But according to study author Lee Jones, an exercise scientist at Memorial Sloan Kettering…

A research study by Tulane University discovered a new pathway for halting lung cancer. It highlights the role of RBM10 in suppressing cancer growth and identifies a mutant form that promotes tumors, paving the way for new treatments. Credit: SciTechDaily.com The findings could lead to the development of a new anti-cancer drug and more personalized lung cancer treatment. A new study by Tulane University has uncovered a previously unknown molecular pathway that could be instrumental to halting lung cancer in its tracks.…

Mount Sinai researchers identified an allergy pathway that improves antitumor immunity in lung cancer. Combining immunotherapy with an allergy drug, dupilumab, yielded significant tumor reduction in a clinical study, suggesting a new approach to enhance cancer treatment. A Mount Sinai study found that blocking an allergy pathway boosts antitumor immunity in lung cancer, with an allergy drug, dupilumab, enhancing the effectiveness of immunotherapy in patients. Researchers at the Icahn School of Medicine at Mount Sinai…

A pill for lung cancer has delivered impressive results in newly published research over the weekend. The pill, called osimertinib, was found to cut the risk of dying in half over a five-year span in those who received it alongside surgery. The treatment is intended for patients whose tumors carry a relatively common type of mutation.Boogeyman Star Sophie Thatcher Wrote Howl's Moving Castle Fan Fiction | io9 InterviewOsimertinib was developed by the company AstraZeneca and is sold under the brand name Tagrisso. It belongs…